Curative treatment of oesophageal carcinoma: current options and future developments
Open Access
- 26 May 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Radiation Oncology
- Vol. 6 (1), 55
- https://doi.org/10.1186/1748-717x-6-55
Abstract
Since the 1980s major advances in surgery, radiotherapy and chemotherapy have established multimodal approaches as curative treatment options for oesophageal cancer. In addition the introduction of functional imaging modalities such as PET-CT created new opportunities for a more adequate patient selection and therapy response assessment. The majority of oesophageal carcinomas are represented by two histologies: squamous cell carcinoma and adenocarcinoma. In recent years an epidemiological shift towards the latter was observed. From a surgical point of view, adenocarcinomas, which are usually located in the distal third of the oesophagus, may be treated with a transhiatal resection, whereas squamous cell carcinomas, which are typically found in the middle and the upper third, require a transthoracic approach. Since overall survival after surgery alone is poor, multimodality approaches have been developed. At least for patients with locally advanced tumors, surgery alone can no longer be advocated as routine treatment. Nowadays, scientific interest is focused on tumor response to induction radiochemotherapy. A neoadjuvant approach includes the early and accurate assessment of clinical response, optimally performed by repeated PET-CT imaging and endoscopic ultrasound, which may permit early adaption of the therapeutic concept. Patients with SCC that show clinical response by PET CT are considered to have a better prognosis, regardless of whether surgery will be performed or not. In non-responding patients salvage surgery improves survival, especially if complete resection is achieved.Keywords
This publication has 55 references indexed in Scilit:
- T raditional i nvasive vs. m inimally invasive e sophagectomy: a multi-center, randomized trial (TIME-trial)BMC Surgery, 2011
- Selected Commentary to "Fifty-five minimally invasive esophagectomies: a single center experience"European Surgery, 2009
- 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal CancerJournal of Nuclear Medicine, 2009
- Recommendations on the Use of 18F-FDG PET in OncologyJournal of Nuclear Medicine, 2008
- Staging investigations for oesophageal cancer: a meta-analysisBritish Journal of Cancer, 2008
- Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal EsophagusAnnals of Surgery, 2007
- Neoadjuvante Radiochemotherapie und ResponseprädiktionDer Onkologe, 2004
- Comparison of three-field esophagectomy for esophageal cancer incorporating open or thoracoscopic thoracotomySurgical Endoscopy, 2003
- Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagusSurgical Endoscopy, 2001
- A Prospective Randomized Trial of Extended Cervical and Superior Mediastinal Lymphadenectomy for Carcinoma of the Thoracic EsophagusThe American Journal of Surgery, 1998